ImmunoGen
IMGN
#2144
Rank
A$13.20 B
Marketcap
A$47.27
Share price
0.00%
Change (1 day)
128.56%
Change (1 year)

ImmunoGen (IMGN) - Total liabilities

Total liabilities on the balance sheet as of September 2023 : A$0.39 Billion

According to ImmunoGen 's latest financial reports the company's total liabilities are A$0.39 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ImmunoGen - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.28 B2.77%
2021-12-31A$0.27 B-20.03%
2020-12-31A$0.34 B-22.36%
2019-12-31A$0.44 B10.16%
2018-12-31A$0.40 B0.84%
2017-12-31A$0.40 B
2016-06-30A$0.48 B36.72%
2015-06-30A$0.35 B273.53%
2014-06-30A$95.04 M-5.43%
2013-06-30A$0.10 B6.76%
2012-06-30A$94.13 M29.9%
2011-06-30A$72.46 M74.58%
2010-06-30A$41.5 M-0.78%
2009-06-30A$41.83 M42.71%
2008-06-30A$29.31 M12.74%
2007-06-30A$26 M-11.67%
2006-06-30A$29.44 M-3.54%
2005-06-30A$30.52 M-17.31%
2004-06-30A$36.91 M60.56%
2003-06-30A$22.98 M-28.07%
2002-06-30A$31.96 M-2.14%
2001-06-30A$32.66 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Seagen
SGEN
A$1.64 B 316.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$121.88 B 30,809.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$137.87 B 34,864.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$118.50 B 29,952.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$171.86 B 43,484.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$175.03 B 44,288.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$94.66 B 23,906.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$99.94 B 25,245.81%๐Ÿ‡ซ๐Ÿ‡ท France